ASSURANCESThe database was retained by the sponsor, but the investigators had access to the complete database. The statistical analyses were performed by the sponsoring company’s statistician and reviewed and approved by all authors. The authors assume full responsibility for the completeness and accuracy of the content of the manuscript. This clinical trial was registered on clinicaltrials.gov with registration number: NCT00384930
Changes in peak urinary flow and voiding efficiency in men with signs and symptoms of benign prostatic hyperplasia during once daily tadalafil treatment
Article first published online: 3 SEP 2009
© 2009 THE AUTHORS. JOURNAL COMPILATION © 2009 BJU INTERNATIONAL
Volume 105, Issue 4, pages 502–507, February 2010
How to Cite
Roehrborn, C. G., Kaminetsky, J. C., Auerbach, S. M., Montelongo, R. M., Elion-Mboussa, A. and Viktrup, L. (2010), Changes in peak urinary flow and voiding efficiency in men with signs and symptoms of benign prostatic hyperplasia during once daily tadalafil treatment. BJU International, 105: 502–507. doi: 10.1111/j.1464-410X.2009.08822.x
- Issue published online: 1 FEB 2010
- Article first published online: 3 SEP 2009
- Accepted for publication 28 May 2009
- 3American Urological Association (AUA) Benign Prostatic Hyperplasia (BPH) Guideline Update Panel. Clinical Guidelines: Management of BPH (‘03/updated’06). Available at: http://www.auanet.org/content/guidelines-and-quality-care/clinical-guidelines.cfm?sub=bph. Accessed June 2009
- 10Lower urinary tract symptoms, benign prostatic hyperplasia, erectile dysfunction, and phosphodiesterase-5 inhibitors. Rev Urol 2004; 6: 121–7.
- 18http://www.uro.at/mm/mm007/EAU_BPH.pdf. Accessed June 2009, , et al. Guidelines on Benign Prostatic hyperplasia (updated March 2004). Available at:
- 19Sanofi Aventis. Uroxatral Prescribing Information 2009. Available at: http://products.sanofi-aventis.us/uroxatral/uroxatral.pdf. Accessed June 2009
- 20Boehringer Ingelheim Pharmaceuticals. Flomax Prescribing Information 2009. Available at: http://bidocs.boehringer-ingelheim.com/BIWebAccess/ViewServlet.ser?docBase=renetnt&folderPath=/Prescribing+Information/PIs/Flomax+Caps/Flomax.pdf. Accessed June 2009
- 21Urodynamic Effects of Tadalafil 20 Mg Once Daily Versus Placebo in Men with Signs and Symptoms of Benign Prostatic Hyperplasia. Eur Urol Suppl 2009; 8: 469, , , , , .
- 22Benign prostatic hyperplasia specific health status measures in clinical research: how much change in the American Urological Association symptom index and the benign prostatic hyperplasia impact index is perceptible to patients? J Urol 1995; 154: 1770–4, , et al.